Phase I trial of PK 10571 in patients with pulmonary arterial hypertension

Trial Profile

Phase I trial of PK 10571 in patients with pulmonary arterial hypertension

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Mar 2015

At a glance

  • Drugs PK 10571 (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions
  • Sponsors Pulmokine
  • Most Recent Events

    • 05 Mar 2015 New trial record
    • 03 Mar 2015 Pulmokine expects to submit an IND application to the US FDA in the fourth quarter of 2015, and commence this phase 1 trial following the clearance of that application, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top